Labor Characteristics and Maternal-Infant Outcomes in Preterm Primiparous Women
Labor Characteristics of Primiparous Women With Spontaneous Preterm Birth at Different Gestational Ages and Their Association With Maternal and Infant Outcomes
1 other identifier
observational
436
1 country
1
Brief Summary
This retrospective observational study evaluates labor characteristics in primiparous women with spontaneous preterm birth at different gestational ages and examines their associations with maternal and neonatal outcomes. Medical records of women who delivered at Shanghai Jiading District Maternity and Child Health Care Hospital between January 1, 2020, and December 31, 2025, are reviewed. Participants are classified according to gestational age at delivery into very preterm (28 to 31+6 weeks), moderate preterm (32 to 33+6 weeks), and late preterm (34 to 36+6 weeks) groups. The study compares the onset and duration of the active phase of labor, cervical dilation rate, and durations of the first and second stages of labor across these gestational-age groups. The study also evaluates the associations between labor duration and maternal and neonatal outcomes, including postpartum blood loss, mode of vaginal delivery, and 5-minute Apgar score. The findings are intended to provide evidence for gestational age-specific and individualized labor management in women with spontaneous preterm birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFirst Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 28, 2026
CompletedSeptember 28, 2026
September 1, 2026
6 years
September 18, 2026
September 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Duration of the Active Phase of Labor
Duration of the active phase of labor, measured in hours, from the onset of the active phase to full cervical dilation (10 cm). The onset of the active phase was defined as the cervical dilation corresponding to the inflection point at which the cervical dilation curve changed from a gradual slope to its maximum slope.
During labor, from the identified onset of the active phase to full cervical dilation (10 cm)
Title Description Time Frame Cervical Dilation at the Onset of the Active Phase
Cervical dilation, measured in centimeters, at the identified onset of the active phase of labor.
At onset of the active phase during the index delivery
Mean Cervical Dilation Rate During the Active Phase
Mean cervical dilation rate, measured in cm/hour, calculated as (10 cm minus cervical dilation at the onset of the active phase) divided by the duration of the active phase.
During labor, from the identified onset of the active phase to full cervical dilation (10 cm)
Duration of the First Stage of Labor
Duration of the first stage of labor, measured in hours, as documented in the obstetric medical record.
During labor, from the documented onset of labor to full cervical dilation (10 cm)
Duration of the Second Stage of Labor
Duration of the second stage of labor, measured in hours, from full cervical dilation to delivery of the fetus.
During labor, from full cervical dilation (10 cm) to fetal delivery
Secondary Outcomes (3)
Postpartum Blood Loss Within 2 Hours After Delivery
From fetal delivery through 2 hours postpartum
Vaginal Delivery Status
At the time of delivery
5-Minute Apgar Score
5 minutes after birth
Study Arms (3)
Very Preterm Group
Primiparous women with spontaneous preterm birth who delivered vaginally at 28 weeks 0 days to 31 weeks 6 days of gestation. This group included 45 participants. No study-specific intervention was assigned; clinical and labor data were retrospectively obtained from existing medical records.
Moderate Preterm Group
Primiparous women with spontaneous preterm birth who delivered vaginally at 32 weeks 0 days to 33 weeks 6 days of gestation. This group included 37 participants. No study-specific intervention was assigned; clinical and labor data were retrospectively obtained from existing medical records.
Late Preterm Group
Primiparous women with spontaneous preterm birth who delivered vaginally at 34 weeks 0 days to 36 weeks 6 days of gestation. This group included 354 participants. No study-specific intervention was assigned; clinical and labor data were retrospectively obtained from existing medical records.
Interventions
Gestational age at delivery was the primary exposure of interest. Participants were retrospectively classified into three groups according to gestational age at delivery: very preterm (28 weeks 0 days to 31 weeks 6 days), moderate preterm (32 weeks 0 days to 33 weeks 6 days), and late preterm (34 weeks 0 days to 36 weeks 6 days). No study-specific intervention was assigned, and all exposure and outcome information was obtained from existing medical records.
Eligibility Criteria
Primiparous women with spontaneous preterm birth who delivered vaginally at Shanghai Jiading District Maternity and Child Health Care Hospital between January 1, 2020, and December 31, 2025, were identified retrospectively from the hospital electronic medical record system. Eligible women had a singleton pregnancy with vertex presentation and delivered between 28 weeks 0 days and 36 weeks 6 days of gestation. Participants were classified according to gestational age at delivery into very preterm, moderate preterm, and late preterm groups.
You may qualify if:
- Primiparous women undergoing vaginal delivery.
- Gestational age at delivery from 28 weeks 0 days to 36 weeks 6 days.
- Spontaneous preterm labor.
- Singleton pregnancy with vertex presentation.
- No labor interventions such as administration of uterotonic agents for labor augmentation or artificial rupture of membranes during labor.
- Complete clinical records.
You may not qualify if:
- Labor induction due to intrauterine fetal demise.
- Twin or multiple pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maternal and Child Health Hospital, Jiading District
Shanghai, Shanghai Municipality, 201821, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 28, 2026
Study Start
January 1, 2020
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 28, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning after publication of the primary study results and will remain available in accordance with the institution's data retention and governance policies.
- Access Criteria
- Qualified researchers may request access to the de-identified individual participant data from the corresponding author for legitimate scientific research purposes. Requests will be reviewed on a case-by-case basis by the study investigators and, where required, the institution. Access will be subject to institutional approval and applicable privacy, confidentiality, and data protection requirements.
De-identified individual participant data underlying the reported study results may be shared with qualified researchers upon reasonable request to the corresponding author. The shared data may include relevant maternal characteristics, gestational age at delivery, labor characteristics, maternal outcomes, and neonatal outcomes. No directly identifiable participant information will be provided. Data sharing will be subject to institutional approval and applicable privacy and data protection requirements.